Diverse physiological effects of long-chain saturated fatty acids: Implications for cardiovascular disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 2, 2013, Pages 133-140

  Flock, Michael R ^a   Kris Etherton, Penny M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

cardiovascular disease; lipids and lipoproteins; saturated fatty acids

Indexed keywords

CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PALMITIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL;

CAPILLARY ENDOTHELIUM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; ESTERIFICATION; FAT INTAKE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; HUMAN; LIPID METABOLISM; LIVER CELL; NONHUMAN; NUTRITION; REVIEW; STEROIDOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL;

CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; LIFE STYLE; RISK FACTORS;

EID: 84873413421     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328359e6ac     Document Type: Review

References (38)

1. Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010; 45:893-905.
2. U.S. Department of Agriculture, ARS. Nutrient intakes from food: mean amounts consumed per individual, by gender and age, What We Eat In America, NHANES 2009-2010. Available: www.ars.usda.gov/ba/bhnrc/fsrg [Accessed 16 July 2012].
3. Bergouignan A, Momken I, Schoeller DA, et al. Metabolic fate of saturated and monounsaturated dietary fats: The Mediterranean diet revisited from epidemiological evidence to cellular mechanisms. Prog Lipid Res 2009; 48:128-147.
4. Nakamura MT, Nara TY. Structure, function, and dietary regulation of D6, D5, and D9 desaturases. Annu Rev Nutr 2004; 24:345-376.
5. Fuhrman BJ, Barba M, Krogh V, et al. Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab 2006; 50:95-102.
6. Lemaitre RN, King IB, Sotoodehnia N, et al. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism 2010; 59:1029-1034.
7. Matsui H, Yokoyama T, Sekiguchi K, et al. Stearoyl-CoA desaturase-1 (SCD1) augments saturated fatty acid-induced lipid accumulation and inhibits apoptosis in cardiac myocytes. PLoS One 2012; 7:e33283.
8. Paton CM, Ntambi JM. Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol 2009; 297:E28-E37.
9. Fabbrini E, Magkos F, Su X, et al. Insulin sensitivity is not associated with palmitoleate availability in obese humans. J Lipid Res 2011; 52:808-812.
10. Cao H, Gerhold K, Mayers JR, et al. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008; 134:933-944.
11. Dimopoulos N, Watson M, Sakamoto K, et al. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J 2006; 399:473-481.
12. Mozaffarian D, Cao H, King IB, et al. Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr 2010; 92:1350-1358.
13. Gertow K, Rosell M, Sjogren P, et al. Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance. Eur J Clin Nutr 2006; 60:1406-1413.
14. Stefan N, Kantartzis K, Celebi N, et al. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care 2010; 33:405-407.
15. Ebbesson SO, Devereux RB, Cole S, et al. Heart rate is associated with red blood cell fatty acid concentration: theGenetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Am Heart J 2010; 159:1020-1025.
16. Wu JH, Lemaitre RN, Imamura F, et al. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study. Am J Clin Nutr 2011; 94:431-438.
17. Mensink RP, Zock PL, Kester AD, et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77:1146-1155.
18. Hunter JE, Zhang J, Kris-Etherton PM. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 2010; 91:46-63.
19. Tholstrup T, Vessby B, Sandstrom B. Difference in effect of myristic and stearic acid on plasma HDL cholesterol within 24 h in young men. Eur J Clin Nutr 2003; 57:735-742.
20. Berglund L, Lefevre M, Ginsberg HN, et al. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr 2007; 86:1611-1620.
21. Lichtenstein AH, Matthan NR, Jalbert SM, et al. Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am J Clin Nutr 2006; 84:497-504.
22. Balk E, Chung M, Lichtenstein A, et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Evid Rep Technol Assess (Summ) 2004; 93:1-6.
23. Kralova Lesna I SP, Kovar J, Stavek P, Poledne R. Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport. J Lipid Res 2008; 49:2414-2418.
24. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7:e1000252.
25. Jakobsen MU, O'Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009; 89:1425-1432.
26. Mente A, de Koning L, Shannon HS, et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009; 169:659-669.
27. Siri-Tarino PW, Sun Q, Hu FB, et al. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010; 91:535-546.
28. Katan MB, Brouwer IA, Clarke R, et al. Saturated fat and heart disease. Am J Clin Nutr 2010; 92:459-460.
29. Willet WC. Dietary fats and coronary heart disease. J Intern Med 2012; 272:13-24.
30. Skeaff CM, Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 2009; 55:173-201.
31. Kromhout D, Geleijnse JM, Menotti A, et al. The confusion about dietary fatty acids recommendations for CHD prevention. Br J Nutr 2012; 106: 627-632.
32. Hooper L, Summerbell CD, Thompson R, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2012:CD002137.
33. Tholstrup T, Hoy CE, Andersen LN, et al. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently? J Am Coll Nutr 2004; 23:169-176.
34. van Meijl LE, Vrolix R, Mensink RP. Dairy product consumption and the metabolic syndrome. Nutr Res Rev 2008; 21:148-157.
35. Siri-Tarino PW, Sun Q, Hu FB, et al. Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients. Curr Atheroscler Rep 2010; 12:384-390.
36. Siri-Tarino PW, Sun Q, Hu FB, et al. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 2010; 91:502-509.
37. Lovegrove JA, Gitau R. Nutrigenetics and CVD: what does the future hold? Proc Nutr Soc 2008; 67:206-213.
38. Ferguson JF, Phillips CM, Tierney AC, et al. Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulat insulin resistance. Am J Clin Nutr 2010; 91:794-801.